We used the incidence of spike gene target failures identified during PCR testing to provide an early projection of the prevalence of severe acute respiratory syndrome coronavirus 2 variant B.1.1.7 in a university setting in Texas, USA, before sequencing results were available. Findings from a more recent evaluation validated those early projections.
All Keywords
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, Testing, variant of concern, B.1.1.7, Texas, Alpha variant, university, 【초록키워드】 coronavirus, Sequencing, variant, severe acute respiratory syndrome Coronavirus, Prevalence, PCR testing, spike gene, B.1.1.7, incidence, respiratory, USA, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, finding, 【제목키워드】 USA, projection, SARS-CoV-2 B.1.1.7, setting,
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, Testing, variant of concern, B.1.1.7, Texas, Alpha variant, university, 【초록키워드】 coronavirus, Sequencing, variant, severe acute respiratory syndrome Coronavirus, Prevalence, PCR testing, spike gene, B.1.1.7, incidence, respiratory, USA, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, finding, 【제목키워드】 USA, projection, SARS-CoV-2 B.1.1.7, setting,
우리는 시퀀싱 결과가 나오기 전에 미국 텍사스에 있는 대학 환경에서 중증 급성 호흡기 증후군 코로나바이러스 2 변이 B.1.1.7의 유병률을 조기에 예측하기 위해 PCR 테스트 중에 확인된 스파이크 유전자 표적 실패의 발생률을 사용했습니다. 보다 최근의 평가 결과는 이러한 초기 예측을 입증했습니다.